Primary stromal cells also significantly induced CLL cell resistance to ATO (67.1% cell viability compared to 14.5% on suspended cells) and the anti-MMP-9 Ab clearly overcame this protective effect, reducing the stroma-induced survival to 18.8% (Figure 6C). The gene discussed is MMP9; the disease is B-cell chronic lymphocytic leukemia.